(Q36801018)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17457361%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Mechanisms of disease: the complement system in renal injury--new ways of looking at an old foe (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17457361%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17457361%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Katherine M Brown

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17457361%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Neil S Sheerin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17457361%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17457361%20AND%20SRC:MED&resulttype=core&format=json

Nature Clinical Practice Nephrology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17457361%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17457361%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17457361%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

277-286

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17457361%20AND%20SRC:MED&resulttype=core&format=json

Complement. Second of two parts

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Complement. First of two parts

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

The complement system in regulation of adaptive immunity

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Non-enteropathic hemolytic uremic syndrome: causes and short-term course.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Letter: Haemolytic-uraemic syndrome: evidence for intravascular C3 activation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Three new polymorphisms in the human complement factor H gene and promoter region.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

The human complement factor H: functional roles, genetic variations and disease associations

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Factor H and atypical hemolytic uremic syndrome: mutations in the C-terminus cause structural changes and defective recognition functions

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Familial haemolytic uraemic syndrome and an MCP mutation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Genetic abnormalities of complement regulators in hemolytic uremic syndrome: how do they affect patient management?

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Successful treatment of factor H-related haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

The role of complement in the development of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Mannose-binding lectin engagement with late apoptotic and necrotic cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Autoantibodies against mannose-binding lectin in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Anti-C1q autoantibodies in murine lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Membranoproliferative glomerulonephritis type II (dense deposit disease): an update

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Complement and complement regulatory proteins as potential molecular targets for vascular diseases

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Increased ammoniagenesis as a determinant of progressive renal injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Localization of the complement regulatory proteins in the normal human kidney

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Membrane attack complex and membrane cofactor protein are related to tubulointerstitial inflammation in various human glomerulopathies

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

C3 is central to the interstitial component of experimental immune complex glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

C5a is important in the tubulointerstitial component of experimental immune complex glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

The mannose-binding lectin-pathway is involved in complement activation in the course of renal ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Identification of the target self-antigens in reperfusion injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Independent pathways of P-selectin and complement-mediated renal ischemia/reperfusion injury.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Predominant role for C5b-9 in renal ischemia/reperfusion injury.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Capillary deposition of C4d complement fragment and early renal graft loss

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Association between mannose-binding lectin levels and graft survival in kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Local synthesis of complement component C3 regulates acute renal transplant rejection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Local extravascular pool of C3 is a determinant of postischemic acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Influence of donor C3 allotype on late renal-transplantation outcome.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Accumulation of immune complexes in glomerular disease is independent of locally synthesized c3

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

CD46 (membrane cofactor protein) acts as a human epithelial cell receptor for internalization of opsonized uropathogenic Escherichia coli.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Strategies of therapeutic complement inhibition

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

A randomized, placebo-controlled trial of complement inhibition in ischemia-reperfusion injury after lung transplantation in human beings

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Pharmacokinetics and safety of TP10, soluble complement receptor 1, in infants undergoing cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Membrane-targeted complement inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0465

7 January 2021

Identifiers

DOI

10.1038/NCPNEPH0465

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17457361%20AND%20SRC:MED&resulttype=core&format=json

release_t73mzuscebeordmv73r2ohav34

29 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t73mzuscebeordmv73r2ohav34

24 November 2022

mapped directly with Wikidata item

1 reference